Good morning, ladies and gentlemen, and welcome to the LENZ Therapeutics' Third Quarter 2024 Conference Call. At this time, all participants are in a listen-only mode. Following prepared remarks from ...
Live Science on MSN20h
LED device treats leading cause of vision loss with light therapy, FDA saysThe Food and Drug Administration will allow a new device to be marketed as a treatment for dry age-related macular degeneration.
Views differ between owners and non-owners of smartglasses. But both groups agree the technology can help people.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback